Clincosm LogoSign in Get a demo

stargardt disease

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Study of Participants Previously Enrolled in the STARLIGHT Study

Enrolling by invitation
  • Stargardt Disease
  • Gene Therapy Product-MCO-010
  • Miami, Florida
  • +1 more
Sep 15, 2023

Stargardt Disease Trial (OCU410ST)

Not yet recruiting
  • Stargardt Disease
  • OCU410ST
  • (no location specified)
Jul 13, 2023

Macular Degeneration, Low Vision, Stargardt Disease Trial in Guangzhou (microperimetric biofeedback training)

Completed
  • Macular Degeneration
  • +2 more
  • microperimetric biofeedback training
  • Guangzhou, Guangdong, China
    MAIA microperimetry
Jun 6, 2023

ABCA4 Retinopathy, Stargardt Disease, Retinal Dystrophy Trial run by the NEI (Metformin HCl)

Recruiting
  • ABCA4 Retinopathy
  • +3 more
  • Metformin hydrochloride
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

G1961E-associated Stargardt Disease

Recruiting
  • Stargardt Disease
  • +4 more
  • No intervention
  • Basel, Basel-Stadt, Switzerland
    University Hospital Basel
Dec 21, 2022

Stargardt Disease Trial in Miami, McAllen (Gene Therapy-vMCO-010)

Active, not recruiting
  • Stargardt Disease
  • Gene Therapy-vMCO-010
  • Miami, Florida
  • +1 more
Nov 28, 2022

Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

Recruiting
  • Retinal Disease
  • +17 more
  • Arm 1
  • Westport, Connecticut
  • +2 more
Nov 25, 2022

Stargardt Disease Trial in Worldwide (Emixustat, Placebo)

Completed
  • Stargardt Disease
  • Beverly Hills, California
  • +28 more
Jun 30, 2022

Stargardt Disease Trial in Westmead, Perth, Taipei (tinlarebant)

Active, not recruiting
  • Stargardt Disease
  • Westmead, New South Wales, Australia
  • +2 more
Apr 25, 2022

Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy Trial in United States (ALK-001, Placebo)

Recruiting
  • Stargardt Disease
  • +3 more
  • Los Angeles, California
  • +6 more
Feb 15, 2022

Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy Trial in Somerville (ALK-001)

Enrolling by invitation
  • Stargardt Disease
  • +3 more
  • Somerville, Massachusetts
    Coordinating Center
Jul 19, 2021

Retinitis Pigmentosa, Leber's Hereditary Optic Neuropathy, Stargardt Disease Trial in Paris (Dynamic pupillometry sessions)

Completed
  • Retinitis Pigmentosa
  • +2 more
  • Dynamic pupillometry sessions
  • Paris, France
    Centre Hospitalier National D'Ophtalùmologie des Quinze-Vingts
May 28, 2021

Stargardt Disease, Macular Atrophy Trial in Dallas (Emixustat)

Completed
Has Results
  • Stargardt Disease
  • Macular Atrophy
  • Dallas, Texas
    (unnamed)
Apr 27, 2021

Age-related Macular Degeneration, Stargardt Disease, Macular Dystrophy Trial in Guarne, Medellin (Acupuncture and massage)

Completed
Has Results
  • Age-related Macular Degeneration
  • +2 more
  • Acupuncture and massage
  • Guarne, Antioquia, Colombia
  • +1 more
Jun 11, 2020

Progression of Stargardt Disease: Retrospective and Prospective

Completed
Has Results
  • Stargardt Disease
    • Baltimore, Maryland
    • +8 more
    Oct 30, 2019

    Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related

    Completed
    • Stargardt Disease
      • Baltimore, Maryland
      • +4 more
      Aug 1, 2018

      Methods for Fluorescence to Detect Progression in Stargardt

      Terminated
      • Stargardt Disease
        • Ann Arbor, Michigan
          Kellogg Eye Center
        Nov 4, 2016

        Stargardt Disease, Age-related Macular Degeneration, Other Retinal Dystrophies Trial (ALK-001 (No generic name))

        Completed
        • Stargardt Disease
        • +2 more
        • ALK-001 (No generic name)
        • (no location specified)
        Mar 21, 2015